Advertisements


New York Blood Center to collect plasma from recovered victims as potential coronavirus treatment

Health officials are hopeful that experimental treatments using the blood could aid future patients......»»

Category: topSource: marketwatchMar 26th, 2020

Montco firm forms alliance to develop coronavirus treatment from blood of recovered patients

King of Prussia-based CSL Behring is teaming up with a group of other plasma-focused biopharmaceutical companies to develop a plasma-derived therapy that could potentially be used to treat COVID-19 patients. Other members of the alliance formed by .....»»

Category: topSource: bizjournalsApr 6th, 2020

A recovered coronavirus patient saved 2 lives after donating her blood plasma. She says she"s "still coming to terms" with that ability.

Marisa Leuzzi Marisa Leuzzi doesn't know how she was exposed to the coronavirus, but the infection led her body to de.....»»

Category: smallbizSource: nytApr 25th, 2020

A woman who recovered from the coronavirus tried to donate her plasma, but she barely had any antibodies. It highlights lingering questions about immunity.

Molly DeMellier 27-year-old Molly DeMellier donated her blood for the Mount Sinai antibody trial a.....»»

Category: topSource: businessinsiderApr 23rd, 2020

Eli Lilly CEO Talks Coronavirus Treatment Progress: "This Is An Important Bridge Therapy"

Drugmaker Eli Lilly And Co (NYSE: LLY) started a human study of a potential antibody treatment for COVID-19 patients, and CEO David Ricks said on Fox Business that it is read more.....»»

Category: blogSource: benzingaJun 1st, 2020

NC drugmaker sees $82 million in federal funding for Covid-19 treatment

A Triangle drug company on the verge of a commercial launch is also bringing in big money to study its potential coronavirus treatment......»»

Category: topSource: bizjournalsMay 10th, 2020

How does Gilead market a pandemic treatment?

In a matter of weeks, remdesivir has gone from a shelved, failed hepatitis C treatment to the center of a national effort to treat patients suffering from covid-19, the illness caused by the novel coronavirus......»»

Category: topSource: moneycentralMay 7th, 2020

How does Gilead market a pandemic treatment?

In a matter of weeks, remdesivir has gone from a shelved, failed hepatitis C treatment to the center of a national effort to treat patients suffering from covid-19, the illness caused by the novel coronavirus......»»

Category: topSource: moneycentralMay 7th, 2020

In the quest for a coronavirus treatment, scientists are turning to a 4-year-old llama named Winter

VIB-UGent Center for Medical Biotechnology/Handout via Rueters Research from Belgian and US scientists suggests that a four-year-o.....»»

Category: topSource: businessinsiderMay 7th, 2020

North Carolina drugmaker Chimerix may have treatment for coronavirus — and another for smallpox

A Triangle drugmaker is beginning trials for a potential treatment for Covid-19, while at the same time the company is close to locking down a federal contract to stockpile treatments for another deadly disease......»»

Category: topSource: bizjournalsMay 6th, 2020

Amgen studying Otezla for coronavirus, looking into other treatments

Amgen Inc on Thursday reported better-than-expected first-quarter results and said it plans to study psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the new coronavirus......»»

Category: topSource: reutersApr 30th, 2020

Gilead to work with partners to ramp up production of potential coronavirus treatment

Gilead Sciences Inc, maker of the experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19 treatment......»»

Category: topSource: reutersApr 30th, 2020

Gilead aims to expand remdesivir output for COVID-19, posts flat 1st-quarter results

Gilead Sciences Inc , maker of the experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19 treatment......»»

Category: topSource: reutersApr 30th, 2020

Amgen studying Otezla for coronavirus, first-quarter results beat Street estimates

Amgen Inc on Thursday reported better-than-expected first-quarter results on Thursday and said it plans to study psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the new coronavirus......»»

Category: topSource: reutersApr 30th, 2020

Gilead aims to expand remdesivir output for COVID-19, posts flat first-quarter results

Gilead Sciences Inc , maker of the experimental coronavirus drug remdesivir, on Thursday reported flat first-quarter earnings and said it with work with international partners to expand production of potential COVID-19 treatment......»»

Category: topSource: reutersApr 30th, 2020

Amid coronavirus distress, wealthy hospitals hoard millions

Gov. Andrew Cuomo outlined how stay-at-home restrictions could be eased for parts of the state. New York Mayor Bill de Blasio said city-run health clinics soon will use a that lets people collect... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkApr 30th, 2020

Boeing CEO sees years of recovery from coronavirus ahead for aviation industry

Gov. Andrew Cuomo outlined how stay-at-home restrictions could be eased for parts of the state. New York Mayor Bill de Blasio said city-run health clinics soon will use a that lets people collect... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkApr 30th, 2020

US stock futures rise after solid tech earnings, Facebook up more than 10%

Stocks ended higher Wednesday on the back of positive data from a potential coronavirus treatment from Gilead Sciences, while traders assessed a sharp drop in U.S. economic activity......»»

Category: topSource: moneycentralApr 30th, 2020

US stock futures rise after solid tech earnings

Stocks ended higher Wednesday on the back of positive data from a potential coronavirus treatment from Gilead Sciences, while traders assessed a sharp drop in U.S. economic activity......»»

Category: topSource: moneycentralApr 30th, 2020

Stocks Jump over 2% on Coronavirus Treatment, Tech Earnings

Stocks Jump over 2% on Coronavirus Treatment, Tech Earnings A potential coronavirus breakthrough led stocks sharply higher Wednesday during a busy session that also included Fed commen.....»»

Category: dealsSource: nytApr 30th, 2020

Stocks close higher on hopes for a virus treatment

Stocks ended higher Wednesday on the back of positive data from a potential coronavirus treatment from Gilead Sciences, while traders assessed a sharp drop in U.S. economic activity......»»

Category: topSource: moneycentralApr 29th, 2020